Some Novel Insights on HPV16 Related Cervical Cancer Pathogenesis Based on Analyses of LCR Methylation, Viral Load, E7 and E2/E4 Expressions

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Das Ghosh, Damayanti ^a   Bhattacharjee, Bornali ^a,e   Sen, Shrinka ^d   Premi, Laikangbam ^a   Mukhopadhyay, Indranil ^a   Chowdhury, Rahul Roy ^b   Roy, Sudipta ^c   Sengupta, Sharmila ^d  

^a INDIAN STATISTICAL INSTITUTE   (India)

^b Saroj Gupta Cancer Centre and Research Institute   (India)

^c Suraksha Diagnostics Private Limited   (India)

^d NATIONAL INSTITUTE OF BIOMEDICAL GENOMICS   (India)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; MESSENGER RNA; PROTEIN E7; REPRESSOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN E2; VIRUS PROTEIN E4;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPISOME; FEMALE; GENE CLUSTER; GENE DISRUPTION; GENE DOSAGE; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC CORRELATION; GENETIC HETEROGENEITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLOMAVIRUS INFECTION; PROTEIN FUNCTION; QUANTITATIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VIRUS; UTERINE CERVIX CANCER; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

BASE SEQUENCE; DNA METHYLATION; DNA PRIMERS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS, VIRAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 84866060807     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044678     Document Type: Article

References (39)

1. Abba MC, Mourón SA, Gómez MA, Dulout FN, Golijow CD, (2003) Association of human papillomavirus viral load with HPV16 and high-grade intraepithelial lesion. Int J Gynecol Cancer 13: 154-158.
2. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, et al. (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121: 621-632.
3. Singh RK, Maulik S, Mitra S, Mondal RK, Basu PS, et al. (2006) Human papillomavirus prevalence in postradiotherapy uterine cervical carcinoma patients: correlation with recurrence of the disease. Int J Gynecol Cancer 16: 1048-1054.
4. Sowjanya AP, Jain M, Poli UR, Padma S, Das M, et al. (2005) Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis 5: 116.
5. zur Hausen H, (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350.
6. Matsukura T, Koi S, Sugase M, (1989) Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology 172: 63-72.
7. Bhattacharjee B, Sengupta S, (2006) HPV16 E2 gene disruption and polymorphisms of E2 and LCR: some significant associations with cervical cancer in Indian women. Gynecol Oncol 100: 372-378.
8. Sathish N, Abraham P, Peedicayil A, Sridharan G, Shaji RV, et al. (2004) E2 sequence variations of HPV 16 among patients with cervical neoplasia seen in the Indian subcontinent. Gynecol Oncol 95: 363-369.
9. Bhattacharjee B, Sengupta S, (2006) CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology 354: 280-285.
10. Bhattacharjee B, Mandal NR, Roy S, Sengupta S, (2008) Characterization of sequence variations within HPV16 isolates among Indian women: prediction of causal role of rare non-synonymous variations within intact isolates in cervical cancer pathogenesis. Virology 377: 143-150.
11. Bhattacharya P, Sengupta S, (2007) Predisposition to HPV16/18-related cervical cancer because of proline homozygosity at codon 72 of p53 among Indian women is influenced by HLA-B*07 and homozygosity of HLA-DQB1*03. Tissue Antigens 70: 283-293.
12. Das D, Bhattacharjee B, Sen S, Mukhopadhyay I, Sengupta S, (2010) Association of viral load with HPV16 positive cervical cancer pathogenesis: causal relevance in isolates harboring intact viral E2 gene. Virology 402: 197-202.
13. Gillitzer E, Chen G, Stenlund A, (2000) Separate domains in E1 and E2 proteins serve architectural and productive roles for cooperative DNA binding. EMBO J 19: 3069-3079.
14. Berg M, Stenlund A, (1997) Functional interactions between papillomavirus E1 and E2 proteins. J Virol 71: 3853-3863.
15. Yasugi T, Benson JD, Sakai H, Vidal M, Howley PM, (1997) Mapping and characterization of the interaction domains of human papillomavirus type 16 E1 and E2 proteins. J Virol 71: 891-899.
16. Van Tine BA, Dao LD, Wu SY, Sonbuchner TM, Lin BY, et al. (2004) Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning. Proc Natl Acad Sci U S A 101: 4030-4035.
17. Baxter MK, McPhillips MG, Ozato K, McBride AA, (2005) The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4. J Virol 79: 4806-4818.
18. Kalantari M, Calleja-Macias IE, Tewari D, Hagmar B, Lie K, et al. (2004) Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J Virol 78: 12762-12772.
19. Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, et al. (1999) Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 59: 6132-6136.
20. Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM, (2006) Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 44: 1755-1762.
21. Kalantari M, Lee D, Calleja-Macias IE, Lambert PF, Bernard HU, (2008) Effects of cellular differentiation, chromosomal integration and 5-aza-2′-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology 374: 292-303.
22. Berumen J, Casas L, Segura E, Amezcua JL, Garcia-Carranca A, (1994) Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes. Int J Cancer 56: 640-645.
23. Berumen J, Ordoñez RM, Lazcano E, Salmeron J, Galvan SC, et al. (2001) Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 93: 1325-1330.
24. Thain A, Jenkins O, Clarke AR, Gaston K, (1996) CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J Virol 70: 7233-7235.
25. Kim K, Garner-Hamrick PA, Fisher C, Lee D, Lambert PF, (2003) Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J Virol 77: 12450-12459.
26. Fernandez AF, Rosales C, Lopez-Nieva P, Graña O, Ballestar E, et al. (2009) The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res 19: 438-451.
27. Brandsma JL, Sun Y, Lizardi PM, Tuck DP, Zelterman D, et al. (2009) Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy. Virology 389: 100-107.
28. Häfner N, Driesch C, Gajda M, Jansen L, Kirchmayr R, et al. (2008) Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene 27: 1610-1617.
29. Ordóñez RM, Espinosa AM, Sánchez-González DJ, Armendáriz-Borunda J, Berumen J, (2004) Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription. J Gen Virol 85: 1433-1444.
30. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, et al. (1997) Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71: 2463-2472.
31. Alloul N, Sherman L, (1999) The E2 protein of human papillomavirus type 16 is translated from a variety of differentially spliced polycistronic mRNAs. J Gen Virol 80 (Pt 1): 29-37.
32. Ziegert C, Wentzensen N, Vinokurova S, Kisseljov F, Einenkel J, et al. (2003) A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques. Oncogene 22: 3977-3984.
33. Romanczuk H, Howley PM, (1992) Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc Natl Acad Sci U S A 89: 3159-3163.
34. Smotkin D, Wettstein FO, (1986) Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci U S A 83: 4680-4684.
35. Jeon S, Lambert PF, (1995) Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci U S A 92: 1654-1658.
36. Badal V, Chuang LS, Tan EH, Badal S, Villa LL, et al. (2003) CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol 77: 6227-6234.
37. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, et al. (1987) Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 61: 962-971.
38. Van Tine BA, Kappes JC, Banerjee NS, Knops J, Lai L, et al. (2004) Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J Virol 78: 11172-11186.
39. Zheng ZM, Baker CC, (2006) Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci 11: 2286-2302.